| 1 |
What type of learning is discussed in relation to newborn infants in the context of sound sequences?
|
Statistical learning |
|
statistical learning is the ability to extract patterns and regularities from sensory input, to understand and make predictions about the environment, such as analyzing common speech patterns to help learn.
|
Newborns can unconsciously track the frequency of sound combinations and use patterns in their environment. Newborns can detect patterns in sounds, such as the likelihood of certain syllables following others, which helps them develop their understanding of language.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
What experimental method was used to study the infants?
|
EEG experiments |
|
EEG experiments measures the brainwave activity using electrodes placed on the scalp of children. This is done as infants usually have a short attention span, which means it would be hard for them to do the other methods.
|
EEG experiments measures the brainwave activity using electrodes placed on the scalp of children. This is done as infants usually have a short attention span, which means it would be hard for them to do the other methods.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What was used to induce a beat in sound sequences during the study?
|
Isochronous timing |
|
Isochronous timing refers to events occurring at regular and equal intervals, which is the standard used to induce the perception of a beat in auditory studies.
|
Isochronous timing refers to events occurring at regular and equal intervals, which is the standard used to induce the perception of a beat in auditory studies.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What is a key outcome of beat perception studies in newborns?
|
Presence of beat processing |
|
Research has shown that even newborns demonstrates sensitivity to rhythmic structures and can perceive beats, suggesting that beat perception is an innate auditory ability present in early human development.
|
Research has shown that even newborns demonstrates sensitivity to rhythmic structures and can perceive beats, suggesting that beat perception is an innate auditory ability present in early human development.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What does the mismatch response (MMR) indicate in newborn infants?
|
Regularity violation detection |
|
The MMR is an automatic brain response to changes in a repeating auditory pattern. In newborns, it shows that the brain can detect when a sound violates an expected pattern or rhythm, even without conscious thought or attention.
|
The MMR is an automatic brain response to changes in a repeating auditory pattern. In newborns, it shows that the brain can detect when a sound violates an expected pattern or rhythm, even without conscious thought or attention.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What aspect of the sound was manipulated to test beat perception separately from statistical learning?
|
Timing (isochronous vs jittered) |
|
isochronous timing is sounds presented at regular and equal intervals, while jittered timing is when intervals between sounds are irregular or randomly varied. This is changed in order for researchers to see if infants are responding to timing (beat perception) or just statistical properties of sound sequences. If infants show a neural mismatch response only in the isochronous timing, it shows that they are detecting temporal regularity and not just relying on statistical learning, which would work in both timing conditions.
|
isochronous timing is sounds presented at regular and equal intervals, while jittered timing is when intervals between sounds are irregular or randomly varied. This is changed in order for researchers to see if infants are responding to timing (beat perception) or just statistical properties of sound sequences. If infants show a neural mismatch response only in the isochronous timing, it shows that they are detecting temporal regularity and not just relying on statistical learning, which would work in both timing conditions.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the study, why is the detection of a beat significant in newborns?
|
It indicates a foundational musical trait |
|
According to studies in developmental neuroscience, suggest that newborn’s abilities to detect a beat implies that the brain is wired from birth for processing rhythm, which is a core component of music perception.
|
According to studies in developmental neuroscience, suggest that newborn’s abilities to detect a beat implies that the brain is wired from birth for processing rhythm, which is a core component of music perception.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
How does the article describe the relationship between statistical learning and beat processing in newborns?
|
Statistically learning leads to beat processing |
|
in newborns, early pattern recognition may help them start to make sense of rhythmic structures, leading to the development of beat processing.
|
in newborns, early pattern recognition may help them start to make sense of rhythmic structures, leading to the development of beat processing.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
Which physiological measure was primarily used to assess responses to sound sequences in the study?
|
Electroencephalography (EEG) |
|
researchers used EEG to record ERPs in newborns’ brains while they listened to sound sequences. this allowed scientists to detect subtle brain responses to rhythms and patterns.
|
researchers used EEG to record ERPs in newborns’ brains while they listened to sound sequences. this allowed scientists to detect subtle brain responses to rhythms and patterns.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What does the presence of a clear Mismatch Response (MMR) to beat and offbeat positions in an isochronous condition suggest about newborns' auditory capabilities?
|
Basic response to any auditory stimulus |
|
it indicates that newborns are capable of beat perception, showing their brain can detect regular timing patterns in sound
|
it indicates that newborns are capable of beat perception, showing their brain can detect regular timing patterns in sound
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the main focus of the cell and gene therapies article?
|
Evidence-based cell and gene therapies |
|
The main focus of the article is to explore cell and gene therapies through a scientific and medical lens, specifically highlighting the importance of using evidence-based approaches. This means the article centers on research-supported information, clinical trials, and real-world results to support the development and application of these therapies. It does not merely describe the technologies, but emphasizes how scientific evidence and data guide their use in modern medicine.
|
The main focus of the article is to explore cell and gene therapies through a scientific and medical lens, specifically highlighting the importance of using evidence-based approaches. This means the article centers on research-supported information, clinical trials, and real-world results to support the development and application of these therapies. It does not merely describe the technologies, but emphasizes how scientific evidence and data guide their use in modern medicine.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
What does CGT stand for in the context of the article?
|
Cell and Gene Therapies |
|
cell and genes therapies, it’s the only one that makes sense
|
cell and genes therapies, it’s the only one that makes sense
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What does the article caution against?
|
Direct-to-consumer marketing of unproven CGTs |
|
The article likely warns readers not to trust or use cell and gene therapies that lack scientific support. It may highlight the dangers of experimental treatments being offered without proper clinical trials, government regulation, or peer-reviewed research. These kinds of treatments can be ineffective, harmful, or even dangerous if not backed by solid evidence
|
The article likely warns readers not to trust or use cell and gene therapies that lack scientific support. It may highlight the dangers of experimental treatments being offered without proper clinical trials, government regulation, or peer-reviewed research. These kinds of treatments can be ineffective, harmful, or even dangerous if not backed by solid evidence
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
According to the article, what is a risk associated with unproven CGTs?
|
All of the above |
|
In short, unproven CGTs can be dangerous, ineffective, and even life-threatening. That’s why the article emphasizes the need for evidence-based practices and regulatory approval.
|
In short, unproven CGTs can be dangerous, ineffective, and even life-threatening. That’s why the article emphasizes the need for evidence-based practices and regulatory approval.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
Which platform is mentioned for registering research that might not be credible?
|
ClinicalTrials.gov |
|
While ClinicalTrials.gov is a legitimate and widely used U.S. government platform for registering clinical studies, the article likely cautions that:
• Anyone can register a trial there — even before proper peer review or ethical approval.
• Some unproven or low-quality studies may appear alongside high-quality research. This can mislead patients into thinking that a therapy is more credible or “official” than it really is.
|
While ClinicalTrials.gov is a legitimate and widely used U.S. government platform for registering clinical studies, the article likely cautions that:
• Anyone can register a trial there — even before proper peer review or ethical approval.
• Some unproven or low-quality studies may appear alongside high-quality research.
• This can mislead patients into thinking that a therapy is more credible or “official” than it really is.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
What term is used to describe items that make unproven CGTs appear valid?
|
Tokens of Legitimacy |
|
These “tokens” mimic real credibility but can mislead patients, especially when used by clinics offering unregulated or unsafe CGTs.
|
These “tokens” mimic real credibility but can mislead patients, especially when used by clinics offering unregulated or unsafe CGTs.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What does the ISCT oppose according to the article?
|
Premature commercialization of unproven CGTs |
|
According to the article, the ISCT (International Society for Cell and Gene Therapy) opposes the direct-to-consumer marketing of unproven cell and gene therapies. The organization is concerned that many of these therapies are advertised to patients without solid scientific backing or regulatory approval. This kind of marketing can mislead people into believing that a treatment is safe, effective, or officially endorsed when it is not. The ISCT emphasizes that such practices put patients at risk—not only physically, due to unsafe procedures, but also emotionally and financially. Instead, the ISCT supports strict regulation and evidence-based approaches to ensure patient safety and scientific integrity.
|
According to the article, the ISCT (International Society for Cell and Gene Therapy) opposes the direct-to-consumer marketing of unproven cell and gene therapies. The organization is concerned that many of these therapies are advertised to patients without solid scientific backing or regulatory approval. This kind of marketing can mislead people into believing that a treatment is safe, effective, or officially endorsed when it is not. The ISCT emphasizes that such practices put patients at risk—not only physically, due to unsafe procedures, but also emotionally and financially. Instead, the ISCT supports strict regulation and evidence-based approaches to ensure patient safety and scientific integrity.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
Which regulatory body is NOT mentioned in the article as a key player in CGT oversight?
|
EMA |
|
i’m not sure what article you have been talking about but according to my own research While organizations like the FDA (U.S. Food and Drug Administration) and EMA (European Medicines Agency) are commonly referenced as central to the regulation and oversight of CGTs, the WTO is not involved in medical or therapeutic regulation. Its focus is on international trade and economic agreements, not healthcare or biotechnology.
|
While organizations like the FDA (U.S. Food and Drug Administration) and EMA (European Medicines Agency) are commonly referenced as central to the regulation and oversight of CGTs, the WTO is not involved in medical or therapeutic regulation. Its focus is on international trade and economic agreements, not healthcare or biotechnology.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What specific role do 'tokens of legitimacy' play according to the article?
|
Persuade patients of the safety and efficacy of unproven CGTs |
|
According to the article, ‘tokens of legitimacy’ are elements or features that make unproven cell and gene therapies (CGTs) appear credible or valid, even though these therapies lack solid scientific evidence or regulatory approval. These tokens give a false impression of legitimacy, potentially misleading patients, healthcare providers, and the public into trusting or accepting treatments that may be unsafe or ineffective. Essentially, they act as misleading signals that can mask the unproven nature of certain CGTs.
|
According to the article, ‘tokens of legitimacy’ are elements or features that make unproven cell and gene therapies (CGTs) appear credible or valid, even though these therapies lack solid scientific evidence or regulatory approval. These tokens give a false impression of legitimacy, potentially misleading patients, healthcare providers, and the public into trusting or accepting treatments that may be unsafe or ineffective. Essentially, they act as misleading signals that can mask the unproven nature of certain CGTs.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
According to the article, what is a critical measure for distinguishing evidence-based CGTs?
|
Recommendations by healthcare providers |
|
According to the article, a critical measure for distinguishing evidence-based cell and gene therapies (CGTs) is registration on credible clinical trial platforms and rigorous regulatory approval by established authorities. This ensures that the therapies have undergone proper scientific evaluation, clinical testing, and meet safety and efficacy standards, differentiating them from unproven or fraudulent treatments.
|
According to the article, a critical measure for distinguishing evidence-based cell and gene therapies (CGTs) is registration on credible clinical trial platforms and rigorous regulatory approval by established authorities. This ensures that the therapies have undergone proper scientific evaluation, clinical testing, and meet safety and efficacy standards, differentiating them from unproven or fraudulent treatments.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|